COVID-19 Archives - Page 15 of 15

Developments

Health Canada approves Spartan Bioscience rapid COVID-19 test

Health Canada approved Spartan Bioscience’s DNA analyzer, the Spartan Cube, as a rapid, accurate and portable COVID-19 test. Closely-held Spartan plans to immediately begin shipping the test to its federal and...

April 13, 2020

Developments

Bellerophon submits IND for INOpulse inhaled nitric oxide for COVID-19

Bellerophon Therapeutics (NASDAQ:BLPH) submitted an IND to the FDA to study INOpulse, a pulsed nitric oxide (NO) system, for the treatment of patients with COVID-19. The IND follows the FDA’s allowance of treatment with...

April 9, 2020

Markets

Analysts cuts Neuronetics PTs citing COVID-19 impact

Analysts for BTIG and Canaccord Genuity slashed their price target for Neuronetics (NASDAQ:STIM) but maintained their “buy” ratings, citing a potential leaner post-pandemic business model. Neuronetics markets the...

April 9, 2020

Developments

Novavax sets first-in-human trial for coronavirus vaccine candidate in mid-May

Novavax (NASDAQ:NVAX) identified a coronavirus vaccine candidate, NVX-CoV2373, using its nanoparticle technology, and will initiate a first-in-human trial in mid-May. Novavax’s Matrix-M adjuvant will be incorporated...

April 8, 2020

Developments

FDA clears Mesoblast IND for remestemcel-L in ARDS caused by COVID-19

Mesoblast (NASDAQ:MESO; ASX:MSB) received clearance from the FDA for an IND application to treat patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 with intravenous infusions of its allogeneic...

April 6, 2020

Developments

Ennaid Therapeutics developing antiviral for COVID-19

Closely held Ennaid Therapeutics is advancing development of ENU200 as a therapeutic to treat the up to 80% of asymptomatic, mild-to-moderate cases of COVID-19 viral infections. ENU200 is a repurposed, patent-pending...

April 2, 2020

Developments

Kleo Pharma in COVID-19 research pact with Green Cross LabCell

Closely held Kleo Pharmaceuticals entered into a research collaboration with South Korea-based Green Cross LabCell, a pioneer in the next generation of allogeneic, or “off-the-shelf” natural killer cell...

March 31, 2020

Feature

Amidst a global pandemic, two biotech companies offer innovative solutions

Since COVID-19 was first identified in China late last year, researchers have been working tirelessly to develop diagnostics, therapeutics and vaccines in an effort to prevent the spread of the SARS-CoV-2 virus. Many...

March 31, 2020

Markets

Analysts see strong rationale for Hepion CRV431’s use in severe COVID-19 cases

Hepion Pharmaceuticals’ (NASDAQ:HEPA) CRV431, a cyclophilin inhibitor with antifibrotic and antiviral properties, may show some effect in the ongoing COVID-19 pandemic, according to Roth Capital Partners and Brookline...

March 20, 2020

Markets

Raymond James sees Profound Medical insulated from COVID-19 fallout

Raymond James reiterated that Profound Medical (TSX:PRN; NASDAQ:PROF) remains its “analyst current favorite” and “2020 Best Pick,” saying Profound is “particularly insulated from the current economic fallout of COVID-19...

March 12, 2020

Tag - COVID-19

Health Canada approves Spartan Bioscience rapid COVID-19 test

Bellerophon submits IND for INOpulse inhaled nitric oxide for COVID-19

Analysts cuts Neuronetics PTs citing COVID-19 impact

Novavax sets first-in-human trial for coronavirus vaccine candidate in mid-May

FDA clears Mesoblast IND for remestemcel-L in ARDS caused by COVID-19

Ennaid Therapeutics developing antiviral for COVID-19

Kleo Pharma in COVID-19 research pact with Green Cross LabCell

Amidst a global pandemic, two biotech companies offer innovative solutions

Analysts see strong rationale for Hepion CRV431’s use in severe COVID-19 cases

Raymond James sees Profound Medical insulated from COVID-19 fallout

Subscribe